Key result
Individuals with both elevated inflammation (CRP >1.0 mg/dL) and living in poverty had a significantly higher 15-year risk of all-cause mortality (HR 2.45) compared to those with low CRP and above poverty.
Why the study?
Chronic systemic inflammation and poverty are both linked to increased mortality risk, but whether they have a synergistic effect on 15-year mortality risk among US adults was unknown.
Does the combination of elevated inflammation and poverty increase 15-year mortality risk in middle-aged and older US adults?
Cohort (n=4,849)
Does the combination of elevated inflammation and poverty increase 15-year mortality risk in middle-aged and older US adults?
Hazard Ratio: 2.45 (95% CI 1.64–3.67)
The synergistic effect of systemic inflammation and poverty significantly increases long-term mortality risk, highlighting the need for targeted screening and interventions in socially disadvantaged populations.
May inform integrated risk assessment in vulnerable groups; leaves open causal mechanisms and intervention targets.
Background: Chronic systemic inflammation and poverty are both linked to an increased mortality risk. The goal of this study was to determine if there is a synergistic effect of the presence of inflammation and poverty on the 15-year risk of all-cause, heart disease and cancer mortality among US adults. Methods: We analyzed the nationally representative National Health and Nutrition Examination Survey (NHANES) 1999 to 2002 with linked records to the National Death Index through the date December 31, 2019. Among adults aged 40 and older, 15-year mortality risk associated with inflammation, C-reactive protein (CRP), and poverty was assessed in Cox regressions. All-cause, heart disease and cancer mortality were the outcomes. Results: Individuals with elevated CRP at 1.0 mg/dL and poverty were at greater risk of 15-year adjusted, all-cause mortality (HR = 2.45; 95% CI 1.64, 3.67) than individuals with low CRP and were above poverty. For individuals with just one at risk characteristic, low inflammation/poverty (HR = 1.58; 95% CI 1.30, 1.93), inflammation/above poverty (HR = 1.59; 95% CI 1.31, 1.93) the mortality risk was essentially the same and substantially lower than the risk for adults with both. Individuals with both elevated inflammation and living in poverty experience a 15-year heart disease mortality risk elevated by 127% and 15-year cancer mortality elevated by 196%. Discussion: This study extends the past research showing an increased mortality risk for poverty and systemic inflammation to indicate that there is a potential synergistic effect for increased mortality risk when an adult has both increased inflammation and is living in poverty.
No takes yet. Share an insight, caveat, or question.
Mainous et al. (2024) conducted a cohort in Mortality risk (all-cause, heart disease, cancer) (n=4,849). Elevated inflammation (CRP >1.0 mg/dL) and poverty vs. Low inflammation and above poverty was evaluated on 15-year adjusted all-cause mortality (HR 2.45, 95% CI 1.64-3.67). Individuals with both elevated inflammation (CRP >1.0 mg/dL) and living in poverty had a significantly higher 15-year risk of all-cause mortality (HR 2.45) compared to those with low CRP and above poverty.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: